Terumo BCTbio

Industry · 8 registered clinical trials.

Status	Trial	Phase	Started
Terminated	Efficacy and Safety of RBCs Derived From Mirasol-treated Whole Blood in Patients Requiring Chronic Transfusion Transfusion Dependent Thalassemia	N/A	2018-04-12
Terminated	Efficacy of Mirasol-treated Apheresis Platelets in Patients With Hypoproliferative Thrombocytopenia Hematologic Malignancies, Hypoproliferative Thrombocytopenia	N/A	2017-05-05
Completed	Survival and Recovery of Radio-labeled Platelets Derived From Mirasol-treated Whole Blood Blood Safety	N/A	2015-04-01
Completed	Clinical and Biological Efficacy of Mirasol-treated Fresh Whole Blood for the Prevention of Transfusion-transm Malaria	N/A	2014-03-01
Completed	Inactivation of Whole Blood With Mirasol Focus of Study: Radiolabel Recovery and Survival of RBCs	Phase 1	2013-06-01
Terminated	Mirasol-Treated Platelets - (Pathogen Reduction Extended Storage Study) Thrombocytopenia	Phase 2 / Phase 3	2010-09-01
Terminated	Feasibility Study of Mirasol-Treated Whole Blood Red Cell Recovery and Survival Healthy	Phase 1	2008-09-10
Completed	Safety and Performance of MIRASOL® PRT Treated Platelet Transfusion Products Thrombocytopenia	EARLY_Phase 1	2005-12-01